This course is offered in English.


1. Course Description:
This course will focus on the recent advances in our understanding of the clinical features and
pathogenesis of a wide rage of neurodegenerative diseases, including Alzheimer’s disease, Parkinson's
disease and parkinsonisms, ataxias, motor neuron diseases, and polyglutamine diseases. Students will
analyze research reports in which a range of proposed cellular processes that may represent the
underlying pathogenic mechanisms in these diseases. Topics link to the proposed cellular processes will
include accumulation of aberrant proteins, protein misfolding, protofibril formation, ubiquitin-
proteosomal pathway, autophagy, ER stress, axonal and dendritic transport, excitotoxic insult, and
mitochondrial dysfunction. The course will especially emphasis and explore genetic contributions to
neurodegenerative disease, as identification of genetic mutations for familial neurodegenerative diseases
has been a major driving force in neurodegenerative research.

2. Textbooks and References:
The instructor will prepare handouts that covered research articles and outlines for the students, and
there is no assigned textbook. Nevertheless, the instructor will encourage students to refer the following
books for additional information.
(1). Molecular Mechanisms of Neurodegenerative Diseases, by Marie-Francoise Chesselet.
Publisher: Humana Press (January 15, 2001).
ISBN: 0896038041.
(2). Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics, by M. Flint Beal, Anthony
E. Lang, Albert C. Ludolph.
Publisher: Cambridge University Press (June 2, 2005).
ISBN: 052181166X.

3. Teaching Methods and Syllabus:
This course will be given in English and the students are assumed to be able to comprehend the lectures.
The instructor will divide the course into lecture and discussion, which will include the presentation of
research articles by students. The instructor will discuss the following topics in depth:
(1). Overview of neurodegenerative diseases.
(2). Alzheimer’s disease.
(3). Parkinson’s disease.
(4). Huntington’s disease and other polyglutamine disorders.
(5). Motor neuron diseases.

4. Evaluation:
Examines will be conducted in both written format and oral presentation.